(i) New Anticancer Agents. Y. Ishima et al. have prepared Snitrosated human serum albumin (SNO-HSA) with many conjugated SNO groups (poly-SNO-HSA) using chemical modification with 2-iminothiolane, which can be a reliable and safe NO donor. The poly-SNO-HSA can be used as an effective multifunctional antitumor agent because NO release from Poly-SNO-HAS is able to inhibit tumor cell growth and induce apoptosis "Poly-s-nitrosated albumin as a safe and effective multifunctional antitumor agent: characterization, biochemistry and possible future therapeutic applications." C-Y. Tu et al. found that histone deacetylases (HDACs) inhibitor, trichostatin A (TSA), is able to attenuate EGFR expression through induction of microRNA-7 expression, which is an off-target activity of TSA to improve the anticancer efficiency of lapatinib-based therapy via HDACindependent manner "Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells. " All together, we hope this special issue will provide new inputs for those who are interested in the development of novel cancer prevention and treatment strategies.
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